Not a surprise. They grew too fast thanks to their Covid19 vaccine development, then apparently didn’t know what to do with their money. Other than acquiring CureVac, that is, which I didn’t hear about before. Was that a smart move, CurveVac had no successful product and also failed to make a vaccine, if I remember correctly.
Not a surprise. They grew too fast thanks to their Covid19 vaccine development, then apparently didn’t know what to do with their money. Other than acquiring CureVac, that is, which I didn’t hear about before. Was that a smart move, CurveVac had no successful product and also failed to make a vaccine, if I remember correctly.